Evidence map›Paper›PMID 40053131›Full record

SynthesisDer Nervenarzt2025

[Utilization of mental health services in Germany during the first year of the COVID-19 pandemic-Systematic review and meta-analysis].

Antranik Erdekian, Miriam Glock, Sophia Huetter, Mike Rueb, Dirk Riedinger, Jutta Stoffers-Winterling, Saskia Lindner, Fabian Baum, Lars P Hölzel, Oliver Tüscher and 3 more

Abstract readSystematic ReviewMeta-AnalysisEnglish Abstract
PubMed Full text at PMC Publisher
In one paragraph

Synthesis in Der Nervenarzt, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Antranik ErdekianUniversitätsklinik und Poliklinik für Psychiatrie, Psychotherapie und Psychosomatik, Universitätsmedizin Halle, Julius-Kühn-Straße 7, 06112, Halle (Saale), Deutschland.
Miriam GlockUniversitätsklinik und Poliklinik für Psychiatrie, Psychotherapie und Psychosomatik, Universitätsmedizin Halle, Julius-Kühn-Straße 7, 06112, Halle (Saale), Deutschland.
Sophia HuetterKlinik für Psychiatrie und Psychotherapie, Universitätsmedizin der Johannes Guttenberg Universität Mainz, Mainz, Deutschland.
Mike RuebKlinik für Psychiatrie und Psychotherapie, LMU Klinikum, Ludwig Maximilians Universität München, München, Deutschland.
Dirk RiedingerKlinik für Psychiatrie und Psychotherapie, Universitätsmedizin der Johannes Guttenberg Universität Mainz, Mainz, Deutschland.
Jutta Stoffers-WinterlingKlinik für Psychiatrie und Psychotherapie, Universitätsmedizin der Johannes Guttenberg Universität Mainz, Mainz, Deutschland.
Saskia LindnerKlinik für Psychiatrie und Psychotherapie, Universitätsmedizin der Johannes Guttenberg Universität Mainz, Mainz, Deutschland.
Fabian BaumZentrum für Evidenzbasierte Gesundheitsversorgung, Universitätsklinikum und Medizinische Fakultät Carl Gustav Carus an der Technischen Universität Dresden, Dresden, Deutschland.
Lars P HölzelKlinik für Psychiatrie und Psychotherapie, Universitätsmedizin der Johannes Guttenberg Universität Mainz, Mainz, Deutschland.
Oliver TüscherUniversitätsklinik und Poliklinik für Psychiatrie, Psychotherapie und Psychosomatik, Universitätsmedizin Halle, Julius-Kühn-Straße 7, 06112, Halle (Saale), Deutschland.
Klaus LiebKlinik für Psychiatrie und Psychotherapie, Universitätsmedizin der Johannes Guttenberg Universität Mainz, Mainz, Deutschland.
Kristina AdorjanKlinik für Psychiatrie und Psychotherapie, LMU Klinikum, Ludwig Maximilians Universität München, München, Deutschland.
Hauke Felix WiegandUniversitätsklinik und Poliklinik für Psychiatrie, Psychotherapie und Psychosomatik, Universitätsmedizin Halle, Julius-Kühn-Straße 7, 06112, Halle (Saale), Deutschland. Hauke.wiegand@uk-halle.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDuring the coronavirus disease 2019 (COVID-19) pandemic studies showed indications of changes in the utilization of inpatient, outpatient and emergency mental healthcare services; however, the level of observation and representativeness of these studies were heterogeneous.

objectivesChanges in the utilization of psychiatric and psychotherapeutic care in the first year of the COVID-19 pandemic were classified through a systematic literature search, evaluation of the quality and observational levels as well as a meta-analysis of the effects. MATERIAL AND

methodsA systematic search was carried out in PubMed, PsycInfo and Embase until June 2023 and a follow-up search in PubMed up to and including October 2024. Data were assigned to the periods first lockdown phase, between lockdown phases, second lockdown phase and entire pandemic year 2020.

resultsA total of 17 studies were included. There were reductions in the number of inpatient admissions for the first lockdown phase of relative risk, RR 0.74, 95% confidence interval CI 0.70-0.79, I

conclusionIn the first year of the COVID-19 pandemic utilization of mental healthcare services was reduced, especially for the inpatient sector. The effects of these significant restrictions are unclear. We therefore propose a mental healthcare surveillance that could promptly record such changes and possible consequences.

Indexed as

COVID-19Mental DisordersMental Health ServicesPatient Acceptance of Health CareGermanyHospitalizationHumansPandemicsSARS-CoV-2Inpatient treatmentOutpatient treatmentPandemic year 2020Psychiatric emergency carePsychotropic drugs

Identifiers

PMID40053131
PMCPMC12058919

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.